Qtron Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
12,413
-4,828
-28% -$636K 0.21% 86
2026
Q1
$2.4M Buy
17,241
+5
+0% +$700 0.33% 50
2025
Q4
$2.12M Buy
17,236
+2,861
+20% +$348K 0.28% 67
2025
Q3
$1.6M Hold
14,375
0.2% 109
2025
Q2
$1.59M Hold
14,375
0.2% 107
2025
Q1
$1.61M Buy
14,375
+3,781
+36% +$390K 0.24% 95
2024
Q4
$979K Buy
10,594
+5,459
+106% +$492K 0.14% 181
2024
Q3
$431K Hold
5,135
0.06% 340
2024
Q2
$352K Sell
5,135
-5,373
-51% -$359K 0.05% 374
2024
Q1
$770K Sell
10,508
-4,549
-30% -$350K 0.11% 244
2023
Q4
$1.22M Buy
15,057
+2,387
+19% +$186K 0.2% 115
2023
Q3
$949K Sell
12,670
-4,909
-28% -$378K 0.18% 135
2023
Q2
$1.35M Hold
17,579
0.26% 83
2023
Q1
$1.46M Hold
17,579
0.3% 78
2022
Q4
$1.51M Sell
17,579
-1,609
-8% -$127K 0.32% 77
2022
Q3
$1.18M Buy
19,188
+1,884
+11% +$119K 0.29% 79
2022
Q2
$1.07M Buy
17,304
+12,218
+240% +$756K 0.24% 104
2022
Q1
$302K Sell
5,086
-10,032
-66% -$641K 0.07% 296
2021
Q4
$1.1M Hold
15,118
0.25% 110
2021
Q3
$1.06M Buy
15,118
+9,407
+165% +$661K 0.28% 92
2021
Q2
$393K Hold
5,711
0.1% 245
2021
Q1
$369K Hold
5,711
0.1% 239
2020
Q4
$333K Hold
5,711
0.09% 259
2020
Q3
$361K Sell
5,711
-985
-15% -$68.3K 0.13% 199
2020
Q2
$515K Hold
6,696
0.21% 133
2020
Q1
$501K Buy
+6,696
New +$463K 0.3% 113

Other funds holding GILD

Qtron Investments's GILD Position: Q2 2026 in Review

Qtron Investments reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $636K and leaving 12,413 shares worth $1.57M. The position accounts for 0.21% of the portfolio, ranked #86.

Qtron Investments first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.4M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Qtron Investments held 12,413 shares of Gilead Sciences worth $1.57M as of Q2 2026.
  • Qtron Investments sold 4,828 Gilead Sciences shares in Q2 2026, an estimated $636K.
  • Gilead Sciences made up 0.21% of Qtron Investments's portfolio in Q2 2026, its #86 holding.
  • Qtron Investments first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Qtron Investments's Gilead Sciences position peaked at $2.4M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.